Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
On Demand
Favorite
Facebook
Tweet
Print
Keith Dunn, PharmD
Gilead Sciences
Disclosure(s): Gilead Sciences: Employee, Stocks/Bonds (Public Company)
Poster(s):
(P-382) Characteristics and Outcomes of People with HIV (PWH) with Suboptimal Adherence on B/F/TAF or Dolutegravir Single-Tablet Regimens (STRs)
Monday, October 20, 2025
12:15 PM - 1:30 PM
US ET